Treatment of recurrent common warts with one low dose of intralesional natural human leukocyte interferon alpha
- PMID: 2260502
Treatment of recurrent common warts with one low dose of intralesional natural human leukocyte interferon alpha
Abstract
Nine patients with recurrent and long lasting common warts were treated with intralesional Hu-IFN-alpha. The schedule was a single dose per wart, ranged between 10(5) and 2 x 10(5) IU. Placebo was also administered in 3 of these patients. Complete remission was observed in 7 of the 9 patients. The pattern of warts involution and the possible interferon mechanism of action are discussed. A significant pain relief, produced by interferon injection was observed in the patients with plantar warts and in one patient with subungueal wart.
Similar articles
-
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris.Arch Dermatol. 1986 Mar;122(3):272-7. Arch Dermatol. 1986. PMID: 3954392 Clinical Trial.
-
Intralesional human lymphoblastoid interferon alpha for the treatment of cutaneous, nongenital viral warts.Arch Dermatol. 1986 Oct;122(10):1098-9. Arch Dermatol. 1986. PMID: 3767394 No abstract available.
-
Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts.Arch Dermatol. 2001 Apr;137(4):451-5. Arch Dermatol. 2001. PMID: 11295925
-
[Treatment of condyloma acuminata using human lymphoblastoid interferon].Hinyokika Kiyo. 1990 Nov;36(11):1295-300. Hinyokika Kiyo. 1990. PMID: 2288309 Review. Japanese.
-
Cutaneous warts: an evidence-based approach to therapy.Am Fam Physician. 2005 Aug 15;72(4):647-52. Am Fam Physician. 2005. PMID: 16127954 Review.
Cited by
-
Topical treatments for cutaneous warts.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD001781. doi: 10.1002/14651858.CD001781.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972052 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical